14-day Premium Trial Subscription Try For FreeTry Free

Zogenix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 446 833 and sold 2 096 567 ZGNX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
0
Buy 446 833 Shares
Sell 2 096 567 Shares

Historical Insider Trades

Date Type Action Person Amount
Mar 07, 2022 Common Stock Sell Breitmeyer James B 1 250
Mar 07, 2022 Stock Option (Right to Buy) Sell Breitmeyer James B 9 375
Mar 07, 2022 Stock Option (Right to Buy) Sell Breitmeyer James B 6 250
Mar 07, 2022 Stock Option (Right to Buy) Sell Breitmeyer James B 9 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Breitmeyer James B 10 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Breitmeyer James B 20 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Breitmeyer James B 22 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Stutts Mary E. 20 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Stutts Mary E. 22 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Bock Louis C 9 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Bock Louis C 20 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Bock Louis C 20 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Bock Louis C 22 000
Mar 07, 2022 Common Stock Sell Tannenbaum Renee P 32 567
Mar 07, 2022 Stock Option (Right to Buy) Sell Tannenbaum Renee P 3 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Tannenbaum Renee P 22 000
Mar 07, 2022 Common Stock Sell Farfel Gail M 16 606
Mar 07, 2022 Stock Option (Right to Buy) Sell Farfel Gail M 30 289
Mar 07, 2022 Stock Option (Right to Buy) Sell Farfel Gail M 14 250
Mar 07, 2022 Stock Option (Right to Buy) Sell Farfel Gail M 45 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Farfel Gail M 52 500
Mar 07, 2022 Stock Option (Right to Buy) Sell Farfel Gail M 35 000
Mar 07, 2022 Stock Option (Right to Buy) Sell Farfel Gail M 30 000
Mar 07, 2022 Restricted Stock Units Sell Farfel Gail M 40 187
Mar 07, 2022 Common Stock Sell Galer Bradley S. 25 022
Click to get the best stock tips daily for free!

About Zogenix

Zogenix Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company’s lead product candidate is the ZX008, a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. It also develops Relday, an injectable formulation of risperidone that is in Phase III clinical trial to treat the symptoms of schizophrenia and bipolar dis... ZGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT